Noninvasive biomarkers to guide intervention: toward personalized patient management in prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Noninvasive biomarkers to guide intervention: toward personalized patient management in prostate cancer

Published:2020-09-02 Issue:5 Volume:5 Page:383-400
ISSN:2380-8993
Container-title:Expert Review of Precision Medicine and Drug Development
language:en
Short-container-title:Expert Review of Precision Medicine and Drug Development

Author:

Frantzi Maria¹,Gomez-Gomez Enrique²,Mischak Harald¹³⁴^ORCID

Affiliation:

1. Department of Biomarker Research, Mosaiques Diagnostics GmbH, Hannover, Germany

2. Urology Department, Reina Sofía University Hospital, Cordoba, Spain

3. BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK

4. Maimonides Institute of Biomedical Research of Cordoba (IMIBIC), University of Cordoba, Cordoba, Spain

Funder

BMBF

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23808993.2020.1804866

Reference112 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017

3. Prevalence of incidental prostate cancer: A systematic review of autopsy studies

4. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

5. Early Detection of Prostate Cancer: AUA Guideline

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting Clinically Significant Prostate Cancer Using Urine Metabolomics via Liquid Chromatography Mass Spectrometry;The World Journal of Men's Health;2024

2. Validation of diagnostic nomograms based on CE–MS urinary biomarkers to detect clinically significant prostate cancer;World Journal of Urology;2022-07-16

3. Validation of diagnostic nomograms based on CE-MS urinary biomarkers to distinguish clinically significant prostate cancer;2022-01-28

4. Developing Novel Drug Candidates and Repurposed Drugs for Prostate Cancer Based on Molecular Profiles;Current Medicinal Chemistry;2021-12

5. Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy?;Diagnostics;2021-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3